Ocugen GA Trial Advances Toward Phase 3
May 1, 2026
Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy
1 min read
False
May 1, 2026
Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy
1 min read
By Rod Solar
April 30, 2026
You’re not making poor decisions; you’re being forced to decide without clear, trustworthy data across your patient journey
4 min read
By
April 16, 2026
As patient expectations and legal scrutiny rise, ophthalmology must strive to measure and document every step of care
4 min read
April 9, 2026
The Elara 900 expands on the existing gold-standard optics of Haag-Streit’s BQ 900, redefining the slit lamp experience for both physicians and patients
7 min read
March 16, 2026
Who are the ophthalmology leaders and influencers whose achievements have advanced the field in the last 12-18 months?
0 min read
By Rod Solar
January 27, 2026
Why sales is a skill eye surgeons must master
7 min read
By Rod Solar
January 8, 2026
Learn how top-performing surgeons create systems, scorecards, and accountability loops that scale results, not dependency
4 min read
By Rod Solar
November 13, 2025
Why your next growth leap won’t come from getting more leads —but from choosing better ones
4 min read
False
False
False
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: